© 1994 Oxford University Press
OTHER |
Dystroglycan: brain localisation and chromosome mapping in the mouse
Molecular Neurobiology Unit, Royal Free Hospital School of Medicine Rowland Hill Street, London NW3 2PF, UK 1Howard Hughes Medical Institute, Beckman Center for Molecular and Genetic Medicine, Stanford University Medical Center Stanford, CA 94305-5428, USA
*To whom correspondence should be addressed
Received April 26, 1994; Revised July 6, 1994; Accepted July 6, 1994
Duchenne muscular dystrophy (DMD) is accompanied by varying degrees of mental retardation. The molecular basis for this is unknown, although at least four dystrophin transcripts regulated by specific promoters and undergoing elaborate splicing control are present in brain areas associated with cognitive function. In muscle the absence of dystrophin causes instability of a dystrophin-associated protein complex (DAPC) linking the cytoskeleton to the extracellular matrix; this disruption is accompanied by muscle necrosis. The laminin-binding component of DAPC, dystroglycan, in contrast to other components of DAPC, has been found in brain homogenates. This suggests that the link between the membrane cytoskeleton and extracellular matrix mediated by dystrophin-dystroglycan may play a functional role in brain. We have cloned a mouse dystroglycan partial cDNA and have mapped this gene in the mouse to chromosome 9. Further, in situ hybridisation to mouse brain sections shows that the dystroglycan gene is expressed in relatively few structures and co-localises with dystrophin mRNA in hippocampus, dentate gyrus, olfactory bulb and Purkinje neurons but, surprisingly, not in the cortex. Dystroglycan is also expressed in those brain areas where the dystrophin-related protein (utrophin) is present. Our results provide a basis for a future characterisation of the role of dystrophin-dystroglycan association in the brain.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. S. Satz, R. Barresi, M. Durbeej, T. Willer, A. Turner, S. A. Moore, and K. P. Campbell Brain and Eye Malformations Resembling Walker-Warburg Syndrome Are Recapitulated in Mice by Dystroglycan Deletion in the Epiblast J. Neurosci., October 15, 2008; 28(42): 10567 - 10575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hishimoto, Q.-R. Liu, T. Drgon, O. Pletnikova, D. Walther, X.-G. Zhu, J. C. Troncoso, and G. R. Uhl Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms Hum. Mol. Genet., December 1, 2007; 16(23): 2880 - 2891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Colognato, J. Galvin, Z. Wang, J. Relucio, T. Nguyen, D. Harrison, P. D. Yurchenco, and C. ffrench-Constant Identification of dystroglycan as a second laminin receptor in oligodendrocytes, with a role in myelination Development, May 1, 2007; 134(9): 1723 - 1736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Barresi and K. P. Campbell Dystroglycan: from biosynthesis to pathogenesis of human disease J. Cell Sci., January 15, 2006; 119(2): 199 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Weickert, R. E. Straub, B. W. McClintock, M. Matsumoto, R. Hashimoto, T. M. Hyde, M. M. Herman, D. R. Weinberger, and J. E. Kleinman Human Dysbindin (DTNBP1) Gene Expression in Normal Brain and in Schizophrenic Prefrontal Cortex and Midbrain Arch Gen Psychiatry, June 1, 2004; 61(6): 544 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Martin Dystroglycan glycosylation and its role in matrix binding in skeletal muscle Glycobiology, August 1, 2003; 13(8): 55R - 66R. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Collins, G. Gorelick, and A. B. Schneider Dystroglycan Is Present in Rat Thyroid and Rat Thyroid Cells and Responds to Thyrotropin Endocrinology, July 1, 2001; 142(7): 3152 - 3162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jacobson, P. D. Cote, S. G. Rossi, R. L. Rotundo, and S. Carbonetto The Dystroglycan Complex Is Necessary for Stabilization of Acetylcholine Receptor Clusters at Neuromuscular Junctions and Formation of the Synaptic Basement Membrane J. Cell Biol., February 5, 2001; 152(3): 435 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Leeb, S. Neumann, A. Deppe, M. Breen, and B. Brenig Genomic Organization of the Dog Dystroglycan Gene DAG1 Locus on Chromosome 20q15.1-q15.2 Genome Res., March 1, 2000; 10(3): 295 - 301. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Bowe, D. B. Mendis, and J. R. Fallon The Small Leucine-Rich Repeat Proteoglycan Biglycan Binds to {alpha}-Dystroglycan and Is Upregulated in Dystrophic Muscle J. Cell Biol., February 21, 2000; 148(4): 801 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Durbeej and K. P. Campbell Biochemical Characterization of the Epithelial Dystroglycan Complex J. Biol. Chem., September 10, 1999; 274(37): 26609 - 26616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. W. Hilgenberg, C. L. Hoover, and M. A. Smith Evidence of an Agrin Receptor in Cortical Neurons J. Neurosci., September 1, 1999; 19(17): 7384 - 7393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Durbeej, M. D. Henry, M. Ferletta, K. P. Campbell, and P. Ekblom Distribution of Dystroglycan in Normal Adult Mouse Tissues J. Histochem. Cytochem., April 1, 1998; 46(4): 449 - 458. [Abstract] [Full Text]
|
|
|
|
|
|
N. R. Smalheiser and E. Kim Purification of Cranin, a Laminin Binding Membrane Protein J. Biol. Chem., June 23, 1995; 270(25): 15425 - 15433. [Abstract] [Full Text] [PDF]
|
|